nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Ileus—Thiotepa—sarcoma	0.0284	0.0284	CcSEcCtD
Potassium Canrenoate—Electrocardiogram abnormal—Mitoxantrone—sarcoma	0.0265	0.0265	CcSEcCtD
Potassium Canrenoate—Ileus—Vincristine—sarcoma	0.0252	0.0252	CcSEcCtD
Potassium Canrenoate—Extravasation—Thiotepa—sarcoma	0.023	0.023	CcSEcCtD
Potassium Canrenoate—Extravasation—Dactinomycin—sarcoma	0.0229	0.0229	CcSEcCtD
Potassium Canrenoate—Ulcer—Dactinomycin—sarcoma	0.0211	0.0211	CcSEcCtD
Potassium Canrenoate—Extravasation—Vincristine—sarcoma	0.0204	0.0204	CcSEcCtD
Potassium Canrenoate—Extravasation—Mitoxantrone—sarcoma	0.0199	0.0199	CcSEcCtD
Potassium Canrenoate—Ulcer—Mitoxantrone—sarcoma	0.0183	0.0183	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Mitoxantrone—sarcoma	0.0171	0.0171	CcSEcCtD
Potassium Canrenoate—Phlebitis—Dactinomycin—sarcoma	0.0168	0.0168	CcSEcCtD
Potassium Canrenoate—Extravasation—Etoposide—sarcoma	0.0165	0.0165	CcSEcCtD
Potassium Canrenoate—Ulcer—Etoposide—sarcoma	0.0153	0.0153	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Epirubicin—sarcoma	0.015	0.015	CcSEcCtD
Potassium Canrenoate—Phlebitis—Mitoxantrone—sarcoma	0.0146	0.0146	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Thiotepa—sarcoma	0.0139	0.0139	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Doxorubicin—sarcoma	0.0139	0.0139	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Vincristine—sarcoma	0.0123	0.0123	CcSEcCtD
Potassium Canrenoate—Phlebitis—Etoposide—sarcoma	0.0122	0.0122	CcSEcCtD
Potassium Canrenoate—Ileus—Epirubicin—sarcoma	0.0114	0.0114	CcSEcCtD
Potassium Canrenoate—Ileus—Doxorubicin—sarcoma	0.0106	0.0106	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Thiotepa—sarcoma	0.0101	0.0101	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Thiotepa—sarcoma	0.0101	0.0101	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Etoposide—sarcoma	0.00996	0.00996	CcSEcCtD
Potassium Canrenoate—Extravasation—Epirubicin—sarcoma	0.00927	0.00927	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Thiotepa—sarcoma	0.00902	0.00902	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Mitoxantrone—sarcoma	0.00876	0.00876	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Mitoxantrone—sarcoma	0.00871	0.00871	CcSEcCtD
Potassium Canrenoate—Extravasation—Doxorubicin—sarcoma	0.00858	0.00858	CcSEcCtD
Potassium Canrenoate—Dysarthria—Epirubicin—sarcoma	0.00855	0.00855	CcSEcCtD
Potassium Canrenoate—Ulcer—Epirubicin—sarcoma	0.00855	0.00855	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Epirubicin—sarcoma	0.00834	0.00834	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Epirubicin—sarcoma	0.00795	0.00795	CcSEcCtD
Potassium Canrenoate—Ulcer—Doxorubicin—sarcoma	0.00792	0.00792	CcSEcCtD
Potassium Canrenoate—Dysarthria—Doxorubicin—sarcoma	0.00792	0.00792	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Mitoxantrone—sarcoma	0.00779	0.00779	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Doxorubicin—sarcoma	0.00772	0.00772	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Doxorubicin—sarcoma	0.00736	0.00736	CcSEcCtD
Potassium Canrenoate—Discomfort—Dactinomycin—sarcoma	0.00733	0.00733	CcSEcCtD
Potassium Canrenoate—Confusional state—Thiotepa—sarcoma	0.00723	0.00723	CcSEcCtD
Potassium Canrenoate—Infection—Thiotepa—sarcoma	0.00712	0.00712	CcSEcCtD
Potassium Canrenoate—Infection—Dactinomycin—sarcoma	0.00707	0.00707	CcSEcCtD
Potassium Canrenoate—Phlebitis—Epirubicin—sarcoma	0.00682	0.00682	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Thiotepa—sarcoma	0.00644	0.00644	CcSEcCtD
Potassium Canrenoate—Discomfort—Mitoxantrone—sarcoma	0.00638	0.00638	CcSEcCtD
Potassium Canrenoate—Infection—Vincristine—sarcoma	0.00632	0.00632	CcSEcCtD
Potassium Canrenoate—Phlebitis—Doxorubicin—sarcoma	0.00631	0.00631	CcSEcCtD
Potassium Canrenoate—Confusional state—Mitoxantrone—sarcoma	0.00624	0.00624	CcSEcCtD
Potassium Canrenoate—Infection—Mitoxantrone—sarcoma	0.00615	0.00615	CcSEcCtD
Potassium Canrenoate—Pain—Thiotepa—sarcoma	0.00613	0.00613	CcSEcCtD
Potassium Canrenoate—Pain—Dactinomycin—sarcoma	0.00608	0.00608	CcSEcCtD
Potassium Canrenoate—Hypotension—Vincristine—sarcoma	0.00594	0.00594	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Thiotepa—sarcoma	0.00591	0.00591	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Dactinomycin—sarcoma	0.00586	0.00586	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Thiotepa—sarcoma	0.00586	0.00586	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Dactinomycin—sarcoma	0.00582	0.00582	CcSEcCtD
Potassium Canrenoate—Hypotension—Mitoxantrone—sarcoma	0.00579	0.00579	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Vincristine—sarcoma	0.00571	0.00571	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Thiotepa—sarcoma	0.00567	0.00567	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Thiotepa—sarcoma	0.00567	0.00567	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Dactinomycin—sarcoma	0.00563	0.00563	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Dactinomycin—sarcoma	0.00563	0.00563	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Epirubicin—sarcoma	0.00559	0.00559	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Mitoxantrone—sarcoma	0.00556	0.00556	CcSEcCtD
Potassium Canrenoate—Pain—Vincristine—sarcoma	0.00544	0.00544	CcSEcCtD
Potassium Canrenoate—Discomfort—Etoposide—sarcoma	0.00531	0.00531	CcSEcCtD
Potassium Canrenoate—Pain—Mitoxantrone—sarcoma	0.00529	0.00529	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vincristine—sarcoma	0.0052	0.0052	CcSEcCtD
Potassium Canrenoate—Confusional state—Etoposide—sarcoma	0.00519	0.00519	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Doxorubicin—sarcoma	0.00517	0.00517	CcSEcCtD
Potassium Canrenoate—Asthenia—Thiotepa—sarcoma	0.00514	0.00514	CcSEcCtD
Potassium Canrenoate—Infection—Etoposide—sarcoma	0.00512	0.00512	CcSEcCtD
Potassium Canrenoate—Asthenia—Dactinomycin—sarcoma	0.00511	0.00511	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Mitoxantrone—sarcoma	0.0051	0.0051	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00506	0.00506	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vincristine—sarcoma	0.00503	0.00503	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Vincristine—sarcoma	0.00503	0.00503	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Thiotepa—sarcoma	0.00491	0.00491	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Mitoxantrone—sarcoma	0.00489	0.00489	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Mitoxantrone—sarcoma	0.00489	0.00489	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Dactinomycin—sarcoma	0.00487	0.00487	CcSEcCtD
Potassium Canrenoate—Hypotension—Etoposide—sarcoma	0.00481	0.00481	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Etoposide—sarcoma	0.00462	0.00462	CcSEcCtD
Potassium Canrenoate—Asthenia—Vincristine—sarcoma	0.00456	0.00456	CcSEcCtD
Potassium Canrenoate—Vomiting—Thiotepa—sarcoma	0.00456	0.00456	CcSEcCtD
Potassium Canrenoate—Vomiting—Dactinomycin—sarcoma	0.00452	0.00452	CcSEcCtD
Potassium Canrenoate—Rash—Thiotepa—sarcoma	0.00452	0.00452	CcSEcCtD
Potassium Canrenoate—Dermatitis—Thiotepa—sarcoma	0.00452	0.00452	CcSEcCtD
Potassium Canrenoate—Rash—Dactinomycin—sarcoma	0.00449	0.00449	CcSEcCtD
Potassium Canrenoate—Asthenia—Mitoxantrone—sarcoma	0.00444	0.00444	CcSEcCtD
Potassium Canrenoate—Pain—Etoposide—sarcoma	0.0044	0.0044	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vincristine—sarcoma	0.00435	0.00435	CcSEcCtD
Potassium Canrenoate—Nausea—Thiotepa—sarcoma	0.00426	0.00426	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Etoposide—sarcoma	0.00424	0.00424	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Mitoxantrone—sarcoma	0.00424	0.00424	CcSEcCtD
Potassium Canrenoate—Nausea—Dactinomycin—sarcoma	0.00423	0.00423	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Etoposide—sarcoma	0.00421	0.00421	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Epirubicin—sarcoma	0.00408	0.00408	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Etoposide—sarcoma	0.00407	0.00407	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Etoposide—sarcoma	0.00407	0.00407	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Epirubicin—sarcoma	0.00406	0.00406	CcSEcCtD
Potassium Canrenoate—Vomiting—Vincristine—sarcoma	0.00404	0.00404	CcSEcCtD
Potassium Canrenoate—Rash—Vincristine—sarcoma	0.00401	0.00401	CcSEcCtD
Potassium Canrenoate—Dermatitis—Vincristine—sarcoma	0.004	0.004	CcSEcCtD
Potassium Canrenoate—Vomiting—Mitoxantrone—sarcoma	0.00394	0.00394	CcSEcCtD
Potassium Canrenoate—Rash—Mitoxantrone—sarcoma	0.0039	0.0039	CcSEcCtD
Potassium Canrenoate—Dermatitis—Mitoxantrone—sarcoma	0.0039	0.0039	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Doxorubicin—sarcoma	0.00378	0.00378	CcSEcCtD
Potassium Canrenoate—Nausea—Vincristine—sarcoma	0.00378	0.00378	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Doxorubicin—sarcoma	0.00376	0.00376	CcSEcCtD
Potassium Canrenoate—Asthenia—Etoposide—sarcoma	0.0037	0.0037	CcSEcCtD
Potassium Canrenoate—Nausea—Mitoxantrone—sarcoma	0.00368	0.00368	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Epirubicin—sarcoma	0.00363	0.00363	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Etoposide—sarcoma	0.00352	0.00352	CcSEcCtD
Potassium Canrenoate—Flatulence—Epirubicin—sarcoma	0.00349	0.00349	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Doxorubicin—sarcoma	0.00336	0.00336	CcSEcCtD
Potassium Canrenoate—Vomiting—Etoposide—sarcoma	0.00327	0.00327	CcSEcCtD
Potassium Canrenoate—Rash—Etoposide—sarcoma	0.00325	0.00325	CcSEcCtD
Potassium Canrenoate—Dermatitis—Etoposide—sarcoma	0.00324	0.00324	CcSEcCtD
Potassium Canrenoate—Flatulence—Doxorubicin—sarcoma	0.00323	0.00323	CcSEcCtD
Potassium Canrenoate—Nausea—Etoposide—sarcoma	0.00306	0.00306	CcSEcCtD
Potassium Canrenoate—Discomfort—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Potassium Canrenoate—Confusional state—Epirubicin—sarcoma	0.00291	0.00291	CcSEcCtD
Potassium Canrenoate—Infection—Epirubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Potassium Canrenoate—Discomfort—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Potassium Canrenoate—Hypotension—Epirubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Potassium Canrenoate—Confusional state—Doxorubicin—sarcoma	0.00269	0.00269	CcSEcCtD
Potassium Canrenoate—Infection—Doxorubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Epirubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Potassium Canrenoate—Hypotension—Doxorubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Potassium Canrenoate—Pain—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Doxorubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Epirubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Epirubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Potassium Canrenoate—Pain—Doxorubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Epirubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Epirubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Doxorubicin—sarcoma	0.0022	0.0022	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Doxorubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Doxorubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Doxorubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Potassium Canrenoate—Asthenia—Epirubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Epirubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Potassium Canrenoate—Asthenia—Doxorubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Potassium Canrenoate—Vomiting—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Doxorubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Potassium Canrenoate—Rash—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Potassium Canrenoate—Dermatitis—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Potassium Canrenoate—Nausea—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Potassium Canrenoate—Vomiting—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Potassium Canrenoate—Rash—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Potassium Canrenoate—Dermatitis—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Potassium Canrenoate—Nausea—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
